251 related articles for article (PubMed ID: 21503574)
21. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
22. Serum peptidome profiling in patients with lung cancer.
Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
[TBL] [Abstract][Full Text] [Related]
23. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
Diamandis EP
Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
[No Abstract] [Full Text] [Related]
24. Evolutionary optimization of peptide substrates for proteases that exhibit rapid hydrolysis kinetics.
Boulware KT; Jabaiah A; Daugherty PS
Biotechnol Bioeng; 2010 Jun; 106(3):339-46. PubMed ID: 20148412
[TBL] [Abstract][Full Text] [Related]
25. Identification of proteolytic cleavage sites by quantitative proteomics.
Enoksson M; Li J; Ivancic MM; Timmer JC; Wildfang E; Eroshkin A; Salvesen GS; Tao WA
J Proteome Res; 2007 Jul; 6(7):2850-8. PubMed ID: 17547438
[TBL] [Abstract][Full Text] [Related]
26. Identification of low-abundance cancer biomarker candidate TIMP1 from serum with lectin fractionation and peptide affinity enrichment by ultrahigh-resolution mass spectrometry.
Ahn YH; Kim KH; Shin PM; Ji ES; Kim H; Yoo JS
Anal Chem; 2012 Feb; 84(3):1425-31. PubMed ID: 22196688
[TBL] [Abstract][Full Text] [Related]
27. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
[TBL] [Abstract][Full Text] [Related]
28. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
29. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
30. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer.
Zhao Y; Jia W; Sun W; Jin W; Guo L; Wei J; Ying W; Zhang Y; Xie Y; Jiang Y; He F; Qian X
J Proteome Res; 2010 Jun; 9(6):3319-27. PubMed ID: 20420461
[TBL] [Abstract][Full Text] [Related]
31. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
32. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
33. Serum peptide/protein profiling by mass spectrometry provides diagnostic information independently of CA125 in women with an ovarian tumor.
Callesen AK; Madsen JS; Iachina M; Vach W; Kruse TA; Jensen ON; Mogensen O
Cancer Biomark; 2010; 6(2):73-82. PubMed ID: 20571233
[TBL] [Abstract][Full Text] [Related]
34. Two novel targeting peptide degrading proteases, PrePs, in mitochondria and chloroplasts, so similar and still different.
Ståhl A; Nilsson S; Lundberg P; Bhushan S; Biverståhl H; Moberg P; Morisset M; Vener A; Mäler L; Langel U; Glaser E
J Mol Biol; 2005 Jun; 349(4):847-60. PubMed ID: 15893767
[TBL] [Abstract][Full Text] [Related]
35. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
36. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
37. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
[TBL] [Abstract][Full Text] [Related]
38. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of protease activity in serum samples of prostate carcinoma patients with metastases.
Dekker LJ; Burgers PC; Charif H; van Rijswijk AL; Titulaer MK; Jenster G; Bischoff R; Bangma CH; Luider TM
Proteomics; 2010 Jun; 10(12):2348-58. PubMed ID: 20394078
[TBL] [Abstract][Full Text] [Related]
40. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
Doucet A; Overall CM
Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
